Professur für Chirurgische Forschung

Schwabachanlage 12
91054 Erlangen

Publikationen (Download BibTeX)

Lan, B., Zeng, S., Grützmann, R., & Pilarsky, C. (2019). The Role of Exosomes in Pancreatic Cancer. International Journal of Molecular Sciences, 20(18).
Engle, D.D., Tiriac, H., Rivera, K.D., Pommier, A., Whalen, S., Oni, T.E.,... Tuveson, D.A. (2019). The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science, 364(6446), 1156-1162.
Casadonte, R., Kriegsmann, M., Perren, A., Baretton, G., Deininger, S.-O., Kriegsmann, K.,... Kriegsmann, J. (2019). Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging. Proteomics Clinical Applications, 13(1).
Britzen-Laurent, N., Straube, J., Waldner, M., Becker, C., Croner, R., Pilarsky, C.,... Stürzl, M. (2018). Loss of IFN-gamma pathway gene expression in tumor cells as mechanism of immune escape of colorectal carcinoma. In CANCER RESEARCH. Chicago, IL, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Liu, B., & Pilarsky, C. (2018). Analysis of DNA Hypermethylation in Pancreatic Cancer Using Methylation-Specific PCR and Bisulfite Sequencing. Methods in molecular biology (Clifton, N.J.), 1856, 269-282.
Krebs, A.M., Mitschke, J., Losada, M.L., Schmalhofer, O., Boerries, M., Busch, H.,... Pilarsky, C. (2017). The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nature Cell Biology, 19(5), 518-529.
Jahny, E., Yang, H., Liu, B., Jahnke, B., Lademann, F., Knoesel, T.,... Pilarsky, C. (2017). The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation. PLoS ONE, 12(1), e0170390.
Christodoulou, E.G., Yang, H., Lademann, F., Pilarsky, C., Beyer, A., & Schroeder, M. (2017). Detection of COPB2 as a KRAS synthetic lethal partner through integration of functional genomics screens. Oncotarget, 8(21), 34283-34297.
Mayerle, J., Kalthoff, H., Reszka, R., Kamlage, B., Peter, E., Schniewind, B.,... Lerch, M.M. (2017). Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut.
Humphris, J.L., Patch, A.-M., Nones, K., Bailey, P.J., Johns, A.L., Mckay, S.,... Pilarsky, C. (2017). Hypermutation In Pancreatic Cancer. Gastroenterology, 152(1), 68-74.e2.
Gingras, M.-C., Covington, K.R., Chang, D.K., Donehower, L.A., Gill, A.J., Ittmann, M.M.,... Pilarsky, C. (2016). Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Reports, 14(4), 907-19.
Zaccagnino, A., Pilarsky, C., Tawfik, D., Sebens, S., Trauzold, A., Novak, I.,... Pilarsky, C. (2016). In silico analysis of the transportome in human pancreatic ductal adenocarcinoma. European Biophysics Journal With Biophysics Letters, 45(7), 749-763.
Bailey, P., Chang, D.K., Nones, K., Johns, A.L., Patch, A.-M., Gingras, M.-C.,... Pilarsky, C. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.
Werner, K., Lademann, F., Thepkaysone, M.-L., Jahnke, B., Aust, D.E., Kahlert, C.,... Pilarsky, C. (2016). Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy. Oncotarget, 7(4), 3984-92.

Zuletzt aktualisiert 2019-24-04 um 10:20